News search
About the CNIC 31 Oct 2023 Dr Sancho heads the CNIC Immunobiology Laboratory, whose work focuses on research into the function of dendritic cells and macrophages, as key immune cells that modulate immunity and inflammation, and the use of these cells in immunotherapy in a wide range of diseases |
Research 26 Oct 2023 Scientists at the CNIC and Hospital de la Princesa-UAM have identified profound changes taking place in dendritic cells during antigen presentation to a lymphocyte via intimate contact called an immune synapse |
Research 23 Oct 2023 This disease, which can trigger sudden death in elite athletes, is caused by genetic mutations that affect proteins responsible for connecting and coordinating the muscle cells (myocytes) in the myocardium the heart’s muscular wall |
About the CNIC 27 Sep 2023 The International Cardio-Oncology Society (ICOS), the Spanish Society of Cardiology (SEC), the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Haematology and Hemotherapy (SEHH) organised the Global Cardio Oncology Summit 2023 between 27-30 September in Madrid. |
Research 31 Aug 2023 A study published in The Lancet Healthy Longevity shows that brain metabolism, detected with advanced imaging techniques, declines more sharply in middle-aged people with a sustained high cardiovascular risk over 5 years |
Research 5 Jul 2023 A multicenter study published in JAMA Cardiology and co-led by scientists at Hadassah Medical Center, Sheba Medical Center, and the CNIC could help in the design of future pharmacological treatments for bicuspid aortic valve |
Research 21 Jun 2023 A new CNIC study shows that low-grade systemic inflammation triggered by subcinical atherosclerosis accelerates epigenetic aging in otherwise healthy young individuals |
Research 24 May 2023 A study by CNIC researchers published in Nature has found that the omega-6 fatty acid gamma-linolenic acid (GLA), present in breast milk, plays an essential role in ensuring the proper functioning of the heart after birth |
Research 21 May 2023 The team led by Dr. Pablo García-Pavía, based at the CNIC and Hospital Puerta de Hierro, has published the first study of a drug able to remove amyloid deposits from the heart |
- ‹ previous
- 4 of 29
- next ›